ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies
PETACH TIKVA, Israel, June 2, 2025 /CNW/ -- ASP Isotopes Inc. (NASDAQ: ASPI) and Isotopia Molecular Imaging Ltd. have entered into a strategic agreement to secure the supply of Gadolinium-160 (Gd-160), a critical precursor isotope for producing Terbium-161 (Tb-161), an emerging medical isotope with significant potential in targeted radiotherapeutics.
This partnership addresses longstanding supply challenges for Gd-160, enabling Isotopia to advance Tb-161-based therapies for prostate cancer, neuroendocrine tumors, and other malignancies.
Under the agreement, ASP Isotopes will leverage its proprietary Quantum Enrichment technology to provide Isotopia with enriched Gd-160, a stable isotope essential for manufacturing Tb-161.
The collaboration combines ASP Isotopes' expertise in large-scale isotope enrichment—previously demonstrated through its production of Ytterbium-176 (Yb-176)—with Isotopia's proven capabilities in commercial-scale medical isotope production. Isotopia has consistently manufactured Lutetium-177 (Lu-177) and maintained weekly Tb-161 production for its clinical trials over the past two years.
Paul Mann, CEO of ASP Isotopes, emphasized the agreement's significance: "By supplying Gd-160, we are eliminating a major bottleneck in the development of Tb-161 therapies. Our investment in enrichment technology positions us to support the radiopharmaceutical industry's growing demand for stable isotopes. This partnership accelerates the path to clinical adoption of Tb-161, which could redefine cancer treatment paradigms."
Dr. Eli Shalom, CEO of Isotopia, highlighted Tb-161's therapeutic advantages: "Tb-161's dual mechanism of action, including Auger electron emissions, enables precise targeting of micro-metastases while minimizing damage to healthy tissues. This partnership ensures a reliable Gd-160 supply chain, allowing us to scale production and advance our Tb-161-labeled drug candidates toward commercialization. We produce in our site in Israel and shortly the production will start in our second site in Indianapolis in the US."
Tb-161's Auger electrons induce double-strand DNA breaks in cancer cells, offering potential advantages over Lu-177 and alpha-emitting isotopes. This precision aligns with the oncology field's shift toward targeted radiotherapeutics, which improve efficacy and reduce side effects. The agreement comes as global interest in radiopharmaceuticals surges, driven by their ability to deliver localized radiation therapy via tumor-seeking molecules.
About ASP Isotopes Inc.
ASP Isotopes Inc. specializes in advanced isotope separation technologies, including its proprietary Aerodynamic Separation Process and Quantum Enrichment, which produce stable isotopes without radioactive waste. The company's initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. The Company has isotope enrichment facilities in Pretoria, South Africa. For more information, please visit www.aspisotopes.com.
About Isotopia Molecular Imaging Ltd.
Isotopia is a global leader in medical isotope production, with facilities in Israel, Europe, and the U.S. Its integrated platform includes cyclotrons, Lu-177 and Tb-161 production sites, and sterile manufacturing capabilities. The company collaborates with researchers and clinicians to develop novel radiopharmaceuticals for diagnostics and targeted therapy.
This partnership positions both companies at the forefront of the radiopharmaceutical revolution, with the potential to expand treatment options for cancer patients worldwide.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
2 hours ago
- Globe and Mail
This AI ETF Could Turn $10,000 Into $40,000 by 2035
There's no denying it -- artificial intelligence (AI) is likely going to have a profound impact on the world over the long term. Entire industries could be altered. It's no wonder management teams are increasingly focused on ways to better position themselves for long-term success. From an investment perspective, perhaps it's starting to make sense that your portfolio should have some exposure to AI. Luckily, investors don't necessarily need to pick individual stocks if they want to benefit from the trend. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » There's one top AI exchange-traded fund (ETF) that could turn $10,000 into $40,000 by 2035. Continue reading to learn more about how to supercharge your portfolio for future success. Looking at the past and future In the last 10 years, the Invesco QQQ Trust (NASDAQ: QQQ) has generated a total return of 414% (as of June 3). This means that a $10,000 investment made in June 2015 would be worth $51,400 today. I don't think anyone in their right mind would complain with that kind of fantastic result. Even better, the expense ratio of 0.20% is a minimal cost to bear for that type of gain. There's no guarantee that past returns will repeat themselves going forward. Let's assume that there is a slowdown. Even so, I wouldn't be surprised if investors who put the same $10,000 in this ETF today see a fourfold gain in the next decade, resulting in a 15% annualized return. There's a lot of talk about how the stock market's current valuation is expensive. But consider that this has been the general narrative for a very long time. Yet that hasn't prevented equity markets from marching higher. The rise of passive investing, ongoing economic expansion, and dominance of tech-driven enterprises have all played a part. I'm fairly confident these trends will continue. Diversified exposure to artificial intelligence The Invesco QQQ Trust can be considered a top AI ETF, even though it contains 100 stocks in total. There is heavy concentration among the top positions, many of which have a meaningful AI focus. The so-called hyperscalers, most notably Amazon, Microsoft, and Alphabet, combined represent 18.9% of the Invesco QQQ Trust's asset base. These dominant companies have leading cloud computing platforms that offer a range of AI tools to their customers. They're collectively planning to spend hundreds of billions of dollars on capital expenditures in 2025 in an effort to bolster their technical infrastructure to better position themselves for an AI future. We can't forget about Nvidia, the biggest beneficiary thus far of the AI boom. It provides the graphics-processing units that power AI data centers, posting unbelievable revenue and profit growth. It's the second-largest holding in the Invesco QQQ Trust. Other top positions are Apple, Meta Platforms, Netflix, and Tesla. There's no doubt that AI has and will keep impacting these businesses in some way as well. Play the long game Investing correctly means having patience. While the AI craze has definitely made some investors rich in a short period of time, that's the wrong mindset to have. When buying the Invesco QQQ Trust, it's critical to keep the attention on the next decade and beyond. AI has the ability to revolutionize many parts of our economy, and this will all take time to play out. As of this writing, the Invesco QQQ Trust trades 2% off its peak. It might be tempting to wait for a bigger pullback to put money to work. However, I believe this is a flawed approach. It's a smart idea to invest early and often, letting compounding work its magic. Investing in this top AI ETF could work wonders for your portfolio between now and 2035. Should you invest $1,000 in Invesco QQQ Trust right now? Before you buy stock in Invesco QQQ Trust, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Invesco QQQ Trust wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $674,395!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $858,011!* Now, it's worth noting Stock Advisor 's total average return is997% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Neil Patel has positions in Invesco QQQ Trust. The Motley Fool has positions in and recommends Alphabet, Amazon, Apple, Meta Platforms, Microsoft, Netflix, Nvidia, and Tesla. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
Globe and Mail
11 hours ago
- Globe and Mail
Why Applied Digital Stock Soared Again Today
Applied Digital (NASDAQ: APLD) stock posted another day of big gains in Friday's trading. The company's share price closed out the daily session up 8.5%. The S&P 500 ended the day up 1%, and the Nasdaq Composite closed the session up 1.2%. Applied Digital stock continued to rocket higher today after the latest jobs report for the Bureau of Labor Statistics (BLS) got a bullish read from investors. The company's share price has now more than doubled over the last week of trading. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » May's jobs data served up a bullish catalyst for Applied Digital stock The BLS published May's employment data today, and investors saw promising signs in the results. Excluding farm jobs, the U.S. economy added 139,000 net jobs last month. Meanwhile, economists had forecast 125,000 net job additions in the period. Because it could have signaled higher inflationary pressures, stronger-than-expected jobs growth could have actually been a negative indicator for Applied Digital and other growth stocks. But the BLS' update also revised April's net jobs growth figure down by 30,000 and March's jobs additions down by 65,000. The new BLS report generally signals that the U.S. economy is growing at a relatively modest pace. In turn, this makes it more likely that the Federal Reserve will lower interest rates this year. If so, that could help maintain strong momentum for Applied Digital stock. What's next for Applied Digital? Applied Digital stock has been on an incredible hot streak after the company announced that it's entered into a new data-center lease agreement with CoreWeave. Through multiple contracts over the next 15 years, Applied Digital expects to generate more than $7 billion in sales from its service agreements with the artificial intelligence (AI) specialist. On the heels of its explosive valuation gains, the data center specialist is now valued at roughly 12 times this year's expected sales. But its big contract win with CoreWeave suggests that the company is primed to enter an explosive new growth phase. Should you invest $1,000 in Applied Digital right now? Before you buy stock in Applied Digital, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Applied Digital wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $674,395!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $858,011!* Now, it's worth noting Stock Advisor 's total average return is997% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 2, 2025
Globe and Mail
13 hours ago
- Globe and Mail
1 Wall Street Analyst Thinks Palantir Will Be a Trillion-Dollar Company. Can It Get There?
Palantir Technologies (NASDAQ: PLTR) has been one of the top-performing stocks of the artificial intelligence (AI) era. Since the start of 2023, the deep data analytics company has returned nearly 2,000% as it's gone from a slow-growth, unprofitable company to a fast-growing, highly profitable business. That transition is largely due to the launch of its Artificial Intelligence Platform (AIP), which provides an AI layer over its other software analytics platforms like Foundry and Gotham, allowing users to easily retrieve data and gain insights by using AI chatbot interfaces that AIP connects to. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Palantir's stock growth has come not just from the strong performance in the business, but also from significant multiple expansion. On a price-to-sales basis, Palantir now trades at a sky-high ratio of 105, a level typically reserved for highly speculative growth stocks. Given that valuation, there are clear questions about whether Palantir can continue to deliver market-beating returns to investors as its market cap has topped $300 billion, making it the most valuable pure-play software company on the stock market. However, one Wall Street analyst thinks that Palantir can not only outperform the S&P 500, but more than triple to $1 trillion. Palantir's path to $1 trillion Wedbush's Dan Ives is one of the biggest AI bulls on Wall Street as he has cheered on stocks like Tesla, Nvidia, and Apple. However, his recent forecast for Palantir stock may be his boldest one yet. Following a sell-off in Palantir stock after its first-quarter earnings report in early May, Ives went on CNBC and predicted that Palantir would reach a valuation of $1 trillion in two to three years. "They are leading when it comes to the AI revolution," said Ives, and he has noted recent wins like selling its Maven Smart System to NATO. Ives also raised his price target on Palantir from $120 to $140 and maintained an outperform rating. The Wedbush analyst didn't give many specifics in his trillion-dollar forecast, though his prediction seems to be more based on the general growth of AI and Palantir's status as a leading data platform as he's also bullish on a number of other AI stocks. However, a recent news report indicated one key tailwind in Palantir's favor. According to a detailed report in The New York Times, the Trump administration has expanded the federal government's relationship with Palantir. The government, which is by far Palantir's biggest customer, is calling for agencies to share data with each other using Palantir's platforms, a move being pushed by the efficiency and cost-cutting effort known as the Department of Government Efficiency. Can Palantir get there? With revenue growth of 39% in its most recent quarter, Palantir is growing fast enough that its revenue would nearly triple over the next three years if it maintained that growth rate. Palantir could deliver even faster growth on the bottom line given the scalability of the subscription software model and its history of expanding its operating margin. However, Palantir's valuation is likely to present a challenge to the trillion-dollar goal as the stock would still be expensive even if its price-to-sales valuation fell by 75%. Over time, its valuation should moderate, though the stock could maintain a premium for years if its growth rate remains strong. Given the strong growth rate, the embrace by the federal government, and the broader demand for AI, the prospects for Palantir's business continue to look strong. However, the stock's valuation makes Palantir unlikely to reach $1 trillion. It's priced to perfection, and any miss from the company or even weakness in the macro economy could sink the stock. While Palantir's surge has been remarkable, its valuation makes it much riskier than bulls like Ives seem to want to admit. Should you invest $1,000 in Palantir Technologies right now? Before you buy stock in Palantir Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Palantir Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $674,395!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $858,011!* Now, it's worth noting Stock Advisor 's total average return is997% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 2, 2025
